About TomegaVax
TomegaVax is a company based in Beaverton (United States) founded in 2011 was acquired by Vir Biotechnology in January 2017.. TomegaVax offers products and services including Mobile Home Sales, Escrow Services, and Advertising Services. TomegaVax operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others.
- Headquarter Beaverton, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$1.98 M (USD), Grant
Mar 03, 2017
-
Investors
Vir Biotechnology
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Vir Biotechnology
(Jan 06, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of TomegaVax
TomegaVax offers a comprehensive portfolio of products and services, including Mobile Home Sales, Escrow Services, and Advertising Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Facilitates buying and selling of mobile homes in Oregon areas
Provides in-house escrow for home transactions and lending
Covers ads for home listings and buyer outreach
Funding Insights of TomegaVax
- Total Funding Total Funding
- Total Rounds 7
- Last Round Grant — $2.0M
-
First Round
First Round
(01 Apr 2012)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2017 | Amount | Grant - TomegaVax | Valuation |
investors |
|
| Jul, 2016 | Amount | Grant - TomegaVax | Valuation |
investors |
|
| Jun, 2014 | Amount | Grant - TomegaVax | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in TomegaVax
TomegaVax has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Vir Biotechnology and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Developer of therapeutics for the treatment of infectious diseases
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by TomegaVax
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - TomegaVax
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tomegavax Comparisons
Competitors of TomegaVax
TomegaVax operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| domain | founded_year | HQ Location |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| domain | founded_year | HQ Location |
Developer of biologics to treat hepatitis B infection
|
|
| domain | founded_year | HQ Location |
Developer of computationally designed VLP vaccines for treating multiple infections
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about TomegaVax
When was TomegaVax founded?
TomegaVax was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Where is TomegaVax located?
TomegaVax is headquartered in Beaverton, United States. It is registered at Beaverton, Oregon, United States.
What does TomegaVax do?
TomegaVax is an immunotherapy company focussed on developing vaccines for viral infections. It has developed a vaccine technology which uses a cytomegalovirus (CMV) vector and provides continuous low-level antigen presentation to maintain an active T-cell-mediated immune shield. It currently has preclinical and clinical CMV-based vaccine programs for chronic and recurring viral infections including Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), Hepatitis B Virus (HBV) and Herpes Simplex Virus (HSV). It also states that the vaccines can not only prophylactically protect against infection but also control existing infections. It claims that these CMV-based vaccines have also demonstrated pre-clinical efficacy in animal models of Tuberculosis (TB), Malaria, Ebola Virus and cancers including prostate cancer and melanoma.
Who are the top competitors of TomegaVax?
TomegaVax's top competitors include Moderna, Adaptive Biotechnologies and Generate Biomedicines.
What products or services does TomegaVax offer?
TomegaVax offers Mobile Home Sales, Escrow Services, and Advertising Services.
Who are TomegaVax's investors?
TomegaVax has 2 investors. Key investors include Vir Biotechnology, and HHS.